These findings have revealed the mechanisms of STEAP3-AS1-induced CRC progression by regulating the STEAP3/GSK3β/Wnt/β-catenin axis, which may act as a possible biomarker or target for the diagnosis and treatment of CRC. Here, GSK3B is linked to colorectal carcinoma.